Autochecked users, Comment administrators, Editors, Interface administrators, Reviewers, Suppressors, Administrators, Widget editors
1,876
edits
Changes
HAEM5:In situ mantle cell neoplasm (view source)
Revision as of 17:02, 4 December 2023
, 17:02, 4 December 2023no edit summary
{{Under Construction}}
{{Under Construction}}
<blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-11-30. The original page can be found at [[HAEM4:In Situ Mantle Cell Neoplasia]].
<blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-12-04. The original page can be found at [[HAEM4:In Situ Mantle Cell Neoplasia]].
}}</blockquote>
}}</blockquote>
==Primary Author(s)*==
==Primary Author(s)*==
==Links==
==Links==
[[Mantle Cell Lymphoma]]
[[HAEM5:Mantle cell lymphoma]]
[[Leukemic Non-Nodal Mantle Cell Lymphoma]]
[[HAEM5:Leukaemic non-nodal mantle cell lymphoma]]
[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]]
[[HAEM5:Chronic lymphocytic leukaemia/small lymphocytic lymphoma]]
National Comprehensive Cancer Network (NCCN) Guidelines. B-cell Lymphomas. Version 5.2022 — July 12, 2022. Accessed July 25, 2022[https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf]
National Comprehensive Cancer Network (NCCN) Guidelines. B-cell Lymphomas. Version 5.2022 — July 12, 2022. Accessed July 25, 2022[https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf]